Skip to content

Effect of Matrix Rhythm Therapy in individuals with facial acne

Effectiveness of Matrix Rhythm Therapy (MaRhyThe) in individuals with mild to moderate facial Acne vulgaris ââ?¬â?? a pilot study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/11/038161
Enrollment
18
Registered
2021-11-22
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Matrix Rhythm Therapy: The face will be divided into four quadrants and longitudinal strokes will be given surrounding the acne lesion area by pushing down the MaRhyThe applicator to ea

Sponsors

KAHER Institute of physiotherapy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Healthy males and females aged between 18 to 40 years clinically diagnosed with mild to moderate acne vulgaris. 2.Investigators global scale (IGA) of acne severity grade 2 and 3. 3.Individuals willing to participate in the study. � Subjects willing to refrain from use of all other topical products ( moisturizer, new brands of makeup, cream, lotions, powders or any other topical products),all acne medications and antibiotics during the treatment period.

Exclusion criteria

Exclusion criteria: 1.Individuals with excessive facial hair. 2.Presence of any skin condition that would interfere with the diagnosis of assessment of any skin condition (e.g. rosacea, dermatitis, psoriasis, squamous cell carcinoma) . 3.History of hypersensitivity or allergy to skin. 4.Pregnant and lactating females

Design outcomes

Secondary

MeasureTime frame
nilTimepoint: nil

Primary

MeasureTime frame
Investigator�s Global Assessment Facial quadrant acne lesion Subject self-assessmentTimepoint: Baseline and 1 week

Countries

India

Contacts

Public ContactSumedha Jessi

KAHER INSTITUTE OF PHYSIOTHERAPY

vijaykage@yahoo.in

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026